Kelley L Coffman-D'Annibale

4PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 11, 2024
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.

Cecilia Monge, Changqing Xie, Yuta Myojin

|Jan 06, 2024
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial.

Kelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge

|Jul 10, 2023
The current landscape of therapies for hepatocellular carcinoma.

Kelley Coffman-D'Annibale, Changqing Xie, Donna M Hrones

|Jan 24, 2023
Top advances of the year: Hepatobiliary cancers.

Kelley L Coffman-D'Annibale, Tim F Greten

Pageof 1

Frequent Collaborators

3 joint publications

Cecilia Monge

2 joint publications

Tim F Greten

1 joint publications

Changqing Xie

1 joint publications

Xin Wei Wang